Status:
UNKNOWN
Continuous Postoperative Use of Low-Dose Combined Oral Contraceptivesfor for Endometriosis-Related Chronic Pelvic Pain
Lead Sponsor:
University Magna Graecia
Conditions:
Endometriosis
Chronic Pelvic Pain
Eligibility:
FEMALE
18-40 years
Phase:
PHASE4
Brief Summary
Because ovarian sex steroids fluctuations during the menstrual cycle are implicated in the pathogenesis of the endometriosis-related chronic pelvic pain (CPP), the oral contraceptives (OCs) are used w...
Detailed Description
Premenopausal women with endometriosis-related CPP scheduled for laparoscopic surgery to our Academic Department of Gynecology will be consecutively enrolled. Subjects with hystologically confirmed en...
Eligibility Criteria
Inclusion
- Premenopausal state
- Endometriosis-related chronic pelvic pain
- Hystologically confirmed endometriosis at laparoscopy
- Subjective severity of pelvic pain by using a visual analogue scale of at least 70
- No immediate desire of pregnancy
Exclusion
- Age ≤18 or ≥ 40
- Previous use of drugs for treating CPP (wash-out period of 3 months), with exclusion of non-steroidal anti-inflammatory drugs
- Contraindication to estro-progestin compounds
- Major medical diseases
- Psychiatric disorders
- Pelvic inflammatory disease
- Adnexal patologies
- Unability to complete the daily diary
- History of alcohol or other drugs abuse
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2010
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00844012
Start Date
May 1 2009
End Date
July 1 2010
Last Update
March 12 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Catanzaro, Italy
Catanzaro, Italy, 88100